Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice

Autor: Danielle Freches, Jacques Van Snick, Kris Huygen, Hannelie Korf, Catherine Uyttenhove, Jean-Christophe Renauld, Marta Romano
Přispěvatelé: UCL - SSS/DDUV - Institut de Duve
Rok vydání: 2010
Předmět:
Microbiology (medical)
medicine.medical_treatment
Interferon-gamma - biosynthesis
Clinical Biochemistry
Immunology
Down-Regulation
Lung - immunology
metabolism

Mycobacterium bovis - immunology
BCG Vaccine - administration & dosage
immunology

Mycobacterium tuberculosis
Tuberculosis - immunology
prevention & control

Interferon-gamma
Mice
medicine
Autovaccines - administration & dosage
immunology

Immunology and Allergy
Animals
Tuberculosis
Interferon gamma
Lung
Mycobacterium bovis
biology
Interleukin-6
Tumor Necrosis Factor-alpha
Interleukin-17
biology.organism_classification
Vaccine Research
Interleukin-6 - metabolism
Interleukin-12
Interleukin-12 - immunology
Up-Regulation
Mice
Inbred C57BL

Cytokine
Tumor Necrosis Factor-alpha - metabolism
Interleukin 12
Autovaccines
BCG Vaccine
Interleukin-17 - metabolism
Female
Immunization
Interleukin 17
Tuberculosis vaccines
BCG vaccine
medicine.drug
Zdroj: Clinical and Vaccine Immunology, Vol. 18, no. 1, p. 95-104 (2011)
ISSN: 1556-679X
Popis: Interleukin-12 (IL-12) and IL-23 (which share a p40 subunit) are pivotal cytokines in the generation of protective Th1/Th17-type immune responses upon infection with the intracellular pathogen Mycobacterium tuberculosis . The role of IL-12 and IL-23 in protection conferred by the tuberculosis vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) is, however, less well documented. By using an autovaccine approach, i.e., IL-12p70 cross-linked with ovalbumin and PADRE peptide formulated with the GSK proprietary adjuvant system AS02 V , we could specifically neutralize IL-12 while leaving the IL-23 axis intact. Neutralization of IL-12 before M. tuberculosis challenge rendered C57BL/6 mice highly susceptible, resulting in 30-fold-higher CFU in spleen and lungs and accelerated mortality. In contrast, neutralization of IL-12 in BCG-vaccinated mice prior to M. tuberculosis challenge only marginally affected vaccine-mediated protection. Analysis of cytokine production in spleen and lungs 3 weeks post-TB challenge by enzyme-linked immunosorbent assay and functional and flow cytometric assays showed significantly reduced mycobacterium-specific gamma interferon (IFN-γ) responses in M. tuberculosis -infected and BCG-vaccinated mice that had been treated with the autovaccine. Purified protein derivative-induced tumor necrosis factor alpha (TNF-α), IL-6, and IL-17A levels, however, were highest in lungs from BCG-vaccinated/IL-12-neutralized animals, and even unstimulated lung cells from these mice produced significant levels of the three cytokines. Mycobacterium-specific IL-4 and IL-5 production levels were overall very low, but IL-12 neutralization resulted in increased concanavalin A-triggered polyclonal secretion of these Th2-type cytokines. These results suggest that TNF-α, IL-6, and IL-17A may be more important pulmonary effector molecules of BCG-mediated protection than IFN-γ in a context of IL-12 deficiency.
Databáze: OpenAIRE